Off-Label Trazodone Prescription: Evidence, Benefits and Risks

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|23|3343-3351

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.23, 2015-01, pp. : 3343-3351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Off-label uses of trazodone: a review

By Bossini Letizia   Casolaro Ilaria   Koukouna Despoina   Cecchini Federica   Fagiolini Andrea  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1707-1717

Informa Healthcare

Access to resources Recommend Favorite

The Issue Is "Off-Evidence," Not "Off-Label"

By McGivney William T.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 6, 2006-07 ,pp. : 529-530

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

An Evidence-Based Review of Off-Label Uses of Polidocanol

By  

Current Clinical Pharmacology, Vol. 12, Iss. 4, 2018-04 ,pp. : 223-230

Bentham Science Publishers

Access to resources Recommend Favorite

Off-label use of topiramate to assist with weight loss is associated with serious risks

By  

Reactions Weekly, Vol. 1, Iss. 1373, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Off-Label Pharmacovigilance

By Edwards I. Ralph  

Drug Safety, Vol. 34, Iss. 10, 2011-10 ,pp. : 795-797

Adis International

Access to resources Recommend Favorite